Every company arrives IC research-complete.
Founder background, market sizing, competitor map, regulatory landscape — attached before the meeting. Analysts spend hours on judgement, not weeks on tab-opening.
Deep research doesn’t scale.
Done by hand, the full work-up on a single company eats the better part of an analyst-week. That math forces a brutal triage: only the deals with the loudest intros ever get it.
Everything in the quiet tail advances on a thin read — or never advances at all.
Four different tools — and none of them stack.
LinkedIn Sales Navigator, Apollo, Clay, scattered founder graphs.
Gartner, Forrester, Statista, and manual spreadsheets.
PitchBook comps, SimilarWeb, G2, hand-drawn maps.
Outside counsel and legal databases — usually skipped entirely.
Each tool solves one flavor. None apply your thesis. None produce cross-deal comparable output.
One evidence corpus. Structured research. A source for every claim.
Once Stage 1 has screened your market, every surviving company goes through Detailed Scope — the same structure for each one, with a source behind every line. Stage 1 is live today; the deeper scopes are rolling out.
Founders & team
Per founder: track record, prior companies, and exit signal — plus founder–market fit and an overall read on team quality.
Market & sizing
TAM / SAM / SOM with the assumptions and sources behind them, and an honest read on how crowded the market is.
Problem, solution & moat
How acute the problem is, how far the product has actually got, and how defensible the unfair advantage really is.
Competitive landscape
The closest competitors — and what actually differentiates this company from them.
Investors & funding
Who is backing the company and the round history — a read on investor quality, not just a list of logos.
Risk & regulatory
Legal and regulatory risk signals surfaced from the evidence, each traced back to a source.
Cross-deal comparable. Focused. Audit-grade.
Same format every time
Apples-to-apples across your whole shortlist — not a different write-up per analyst.
Spent only on survivors
Detailed Scope runs only on companies your thesis has already advanced — never on dead deals.
Every claim has a source
Each line traces back to where it came from, graded by how well it’s sourced. IC questions get answered, not deferred.
The rest of the platform.
Scale & Coverage
Review your entire sector with one thesis applied to every company — not the few hundred a team can read by hand.
Learn moreInvestment Thesis as Code
Your investment thesis as code — encoded, versioned, and sharper with every override.
Learn moreBuilt for Corporate VCs
Parent-company strategic fit as a first-class evaluation dimension.
Learn moreBring a deal. Get a dossier.
Send us a Stage 1 survivor from your pipeline. We’ll run Detailed Scope and walk you through the output.